跳至主要内容
临床试验/NCT04159376
NCT04159376Unknown不适用

Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases

Tel-Aviv Sourasky Medical Center0 个研究点目标入组 150 人开始时间: 2019年12月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
主要终点
The investigators will report about the number of patients who preformed PET/MR for assessment of skeletal involvement as well as activity after treatment,

研究概览

简要总结

The great promise of PET/MR for assessment of skeletal metastatic involvement is derived from the extensive experience with stand- alone MR, but initial data on the use of PET/MR for assessment of bone pathology indicate that PET/MR introduces unique issues that should be addressed when determining its role in this clinical scenario.

In this study cohort includes 150 patients 18 years or older, having metastatic skeletal involvement on baseline PET/CT prior to treatment. Baseline studies and follow up studies of the patients referred post treatment, will be reviewed.

The main goal of the study is to asses the accuracy of PET/MR in detection and monitoring response of bone metastases.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 150 patients having metastatic skeletal involvement on baseline PET/CT prior to treatment

排除标准

  • Pregnant or breast feeding patients.

结局指标

主要结局

The investigators will report about the number of patients who preformed PET/MR for assessment of skeletal involvement as well as activity after treatment,

时间窗: 1 year

and also preformed in routine PET/CT and to optimize the algorithm of MR-based attenuated PET images.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验